Kewaunee Scientific Co. (NASDAQ:KEQU) Short Interest Down 24.0% in February

Kewaunee Scientific Co. (NASDAQ:KEQU) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 46,500 shares, a decrease of 24.0% from the February 13th total of 61,200 shares. Based on an average trading volume of 27,200 shares, the short-interest ratio is currently 1.7 days. Currently, 2.2% of the company’s shares are short sold.

Kewaunee Scientific Stock Down 2.7 %

NASDAQ:KEQU traded down $1.36 during mid-day trading on Tuesday, hitting $49.69. The stock had a trading volume of 31,954 shares, compared to its average volume of 22,287. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific has a twelve month low of $30.82 and a twelve month high of $71.33. The company has a market capitalization of $142.71 million, a PE ratio of 7.87 and a beta of 0.71. The stock has a 50-day simple moving average of $58.39 and a two-hundred day simple moving average of $47.80.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The business had revenue of $67.17 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday.

Insider Buying and Selling

In other news, VP Douglas J. Batdorff sold 3,470 shares of the stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $65.50, for a total transaction of $227,285.00. Following the sale, the vice president now owns 5,000 shares of the company’s stock, valued at approximately $327,500. This represents a 40.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Donald T. Gardner III sold 2,049 shares of Kewaunee Scientific stock in a transaction that occurred on Tuesday, December 24th. The shares were sold at an average price of $58.19, for a total transaction of $119,231.31. Following the completion of the transaction, the chief financial officer now owns 22,615 shares of the company’s stock, valued at $1,315,966.85. This trade represents a 8.31 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,144 shares of company stock valued at $629,216. Corporate insiders own 14.20% of the company’s stock.

Institutional Investors Weigh In On Kewaunee Scientific

Hedge funds and other institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC raised its holdings in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after acquiring an additional 900 shares during the last quarter. Janney Montgomery Scott LLC acquired a new position in Kewaunee Scientific in the fourth quarter valued at $338,000. Barclays PLC purchased a new position in shares of Kewaunee Scientific during the third quarter worth about $121,000. Finally, IFP Advisors Inc acquired a new stake in shares of Kewaunee Scientific during the fourth quarter worth about $36,000. Institutional investors and hedge funds own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.